NVWM LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Buy |
10,128
+10,087
| +24,602% | +$1.08M | 0.26% | 116 |
|
2025
Q1 | $4.14K | Sell |
41
-92
| -69% | -$9.28K | ﹤0.01% | 331 |
|
2024
Q4 | $11.9K | Hold |
133
| – | – | ﹤0.01% | 291 |
|
2024
Q3 | $11.1K | Hold |
133
| – | – | ﹤0.01% | 296 |
|
2024
Q2 | $10.2K | Sell |
133
-235
| -64% | -$18.1K | ﹤0.01% | 303 |
|
2024
Q1 | $25.2K | Sell |
368
-65
| -15% | -$4.45K | 0.01% | 255 |
|
2023
Q4 | $25K | Hold |
433
| – | – | 0.01% | 262 |
|
2023
Q3 | $22.9K | Hold |
433
| – | – | 0.01% | 270 |
|
2023
Q2 | $23.4K | Buy |
433
+250
| +137% | +$13.5K | 0.01% | 287 |
|
2023
Q1 | $9.16K | Sell |
183
-92
| -33% | -$4.6K | ﹤0.01% | 348 |
|
2022
Q4 | $12.7K | Hold |
275
| – | – | ﹤0.01% | 311 |
|
2022
Q3 | $11K | Hold |
275
| – | – | ﹤0.01% | 323 |
|
2022
Q2 | $10K | Hold |
275
| – | – | ﹤0.01% | 342 |
|
2022
Q1 | $12K | Hold |
275
| – | – | ﹤0.01% | 363 |
|
2021
Q4 | $12K | Hold |
275
| – | – | ﹤0.01% | 367 |
|
2021
Q3 | $12K | Hold |
275
| – | – | ﹤0.01% | 345 |
|
2021
Q2 | $12K | Hold |
275
| – | – | ﹤0.01% | 322 |
|
2021
Q1 | $11K | Hold |
275
| – | – | ﹤0.01% | 306 |
|
2020
Q4 | $10K | Hold |
275
| – | – | ﹤0.01% | 287 |
|
2020
Q3 | $11K | Hold |
275
| – | – | 0.01% | 265 |
|
2020
Q2 | $10K | Hold |
275
| – | – | 0.01% | 246 |
|
2020
Q1 | $9K | Sell |
275
-418
| -60% | -$13.7K | 0.01% | 236 |
|
2019
Q4 | $31K | Hold |
693
| – | – | 0.02% | 197 |
|
2019
Q3 | $28K | Hold |
693
| – | – | 0.02% | 226 |
|
2019
Q2 | $30K | Sell |
693
-15,226
| -96% | -$659K | 0.02% | 226 |
|
2019
Q1 | $611K | Buy |
15,919
+558
| +4% | +$21.4K | 0.4% | 81 |
|
2018
Q4 | $543K | Buy |
15,361
+1,705
| +12% | +$60.3K | 0.41% | 79 |
|
2018
Q3 | $526K | Buy |
13,656
+341
| +3% | +$13.1K | 0.33% | 97 |
|
2018
Q2 | $435K | Buy |
+13,315
| New | +$435K | 0.3% | 104 |
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$25K | – | 332 |
|
2017
Q4 | $25K | Buy |
+1,000
| New | +$25K | 0.02% | 201 |
|